stockrow
Friday 6 November 2026
Export BTSG’s income statement to Excel — free account
BrightSpring Health Services, Inc.
BTSG Healthcare Health Information Services
BrightSpring Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.9 billion, up 28.2% from fiscal 2024.
- Revenue
- +26.4%
- EPS
- +79.4%
- Free cash flow
- +97.7%
- Total debt
- −13.2%
Quarter to September 2026, against a year earlier
67.15
1.29
+1.96%
Follow BTSG
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
39.84 | 28.03 | 38.96 | 28.31 |
P/S ratio |
0.59 | 0.64 | 1.00 | 0.77 | |
P/FCF ratio |
19.22 | 21.17 | 35.71 | 23.86 | |
P/Operating CF |
32.76 | 70.95 | 327.20 | 57.50 | |
P/B ratio |
4.05 | 4.41 | 7.01 | 5.40 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.78 | 0.76 | 1.11 | 0.87 | |
EV/EBITDA |
21.28 | 19.21 | 25.84 | 19.16 | |
EV/Operating CF |
20.44 | 20.22 | 31.64 | 21.94 | |
EV/FCF |
25.39 | 25.10 | 39.82 | 26.86 | |
Quick Ratio |
0.58 | 1.29 | 1.09 | 1.13 | |
Current Ratio |
1.57 | 1.74 | 1.59 | 1.62 | |
Net Debt/EBITDA |
16.17 | 9.93 | 9.46 | 7.33 | |
Debt/Assets |
39.33% | 40.41% | 36.82% | 35.00% | |
Debt/Equity |
1.35 | 1.27 | 1.08 | 1.01 | |
Asset Turnover |
2.09 | 2.26 | 2.41 | 2.48 | |
Operating CF/Net income |
3.00 | 0.83 | 0.52 | 2.04 | |
Capex/Depreciation |
(0.89) | (0.51) | (0.65) | (0.54) | |
Interest Coverage |
2.81 | 3.15 | 3.54 | 5.17 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.57% | 9.98% | 9.36% | 8.50% | |
Intangible Assets out of Total Assets |
0.48 | 0.49 | 0.51 | 0.48 | |
Share Based Compensation of Revenue |
0.40% | 0.10% | 0.50% | 0.42% | |
Graham Net Nets |
(0.22) | (0.18) | (0.10) | (0.11) | |
Graham Number |
13.99 | 18.18 | 20.01 | 21.78 | |
Earnings Yield |
2.51% | 3.57% | 2.57% | 3.53% | |
Free Cash Flow Yield |
5.20% | 4.72% | 2.80% | 4.19% | |
Revenue per Share |
17.53 | 17.65 | 18.80 | 20.35 | |
Operating CF per Share |
1.14 | 0.60 | 0.21 | 0.99 | |
Capex per Share |
(0.19) | (0.11) | (0.14) | (0.11) | |
Free Cash Flow per Share |
0.96 | 0.50 | 0.07 | 0.88 | |
Cash per Share |
0.44 | 4.34 | 2.67 | 3.47 | |
Shareholders Equity per Share |
9.26 | 9.67 | 9.94 | 10.51 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.26 | 9.67 | 9.94 | 10.51 | |
Free Cash Flow |
193.89 | 101.40 | 14.88 | 182.23 | |
Working Capital |
1,045.02 | 1,140.89 | 914.34 | 1,054.94 | |
Capital Expenditures |
(37.66) | (21.54) | (29.03) | (22.09) | |
Net Current Asset Value |
(1,644.12) | (1,544.63) | (1,466.96) | (1,324.25) | |
EV/EBIT |
33.94 | 28.27 | 35.78 | 25.41 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
25.69 | 23.84 | 32.09 | 22.57 | |
| Other line items | |||||
Average Receivables |
946.25 | 1,044.40 | 1,056.07 | 1,114.65 | |
Average Payables |
1,070.94 | 979.76 | 1,028.11 | 1,093.39 | |
Average Inventory |
725.87 | 546.90 | 600.24 | 655.39 | |
Average Assets |
6,169.73 | 6,030.13 | 5,964.66 | 6,158.06 | |
Average Common Equity |
1,761.50 | 1,833.31 | 1,895.70 | 1,997.64 |
Columns are period end dates · fundamentals updated 6 Nov 2026